These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1570457)

  • 1. [Medical interruption of pregnancy. Indications and techniques. Critical study and reflections on 324 cases].
    Persch M; Abrar D; Léonard J; Bonhomme JP; Simon E; Gillet JY
    Rev Fr Gynecol Obstet; 1992 Feb; 87(2):70-5. PubMed ID: 1570457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ethical problems raised by the current French practice of therapeutic abortions. Part I: prospective study for 24 months at the University Hospital of Tours (76 cases)].
    Gold F; Descamps P; Toutain A; Pierre F; Body G; Haddad G; Paillet C; Pourcelot D; Lacombe A; Santini JJ
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(6):586-94. PubMed ID: 8830076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Medical abortion in the second and third trimester. Report of 125 indications from 1992 to 1995].
    Marret H; Perrotin F; Descamps P; de Magalhaes A; Lansac J; Body G
    J Gynecol Obstet Biol Reprod (Paris); 1999 Jun; 28(3):245-52. PubMed ID: 10456307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress in methods of therapeutical abortions during the second trimester in gynecological clinic "Umbal - Pleven"].
    Stoĭkov S; Emin A; Tablov V
    Akush Ginekol (Sofiia); 2005; 44(4):21-6. PubMed ID: 16028374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Terminations of pregnancy for maternal indications in the Paris area: a retrospective multicenter study in the period between the 2001 French law on termination of pregnancy and the new bioethics law].
    Piel B; Azria E; Oury JF; Carbillon L; Mandelbrot L
    J Gynecol Obstet Biol Reprod (Paris); 2013 Jun; 42(4):342-50. PubMed ID: 23718924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic termination of pregnancy. Diagnosis and protocols. 54 cases].
    Berger D; Odent S; Lévêque J; Milon J; Grall JY; Poulain P
    Rev Fr Gynecol Obstet; 1991; 86(7-9):498-502. PubMed ID: 1754804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ethical problems with the current French practice in therapeutic abortions. Part 2: survey by questionnaire in 15 french university hospitals].
    Gold F; Blond MH; Hervé C; Taurelle R; Marchand S; Guérois M
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(7):722-6. PubMed ID: 8568180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of maternal morbidity after drug-induced termination of pregnancy (TOP) after 12 gestation weeks].
    Guillem P; Racinet C; Leynaud A; Benbassa A; Cans C
    J Gynecol Obstet Biol Reprod (Paris); 2003; 32(3 Pt 1):227-38. PubMed ID: 12773925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [RU 486 (mifepristone) and therapeutic abortions in the second and third trimesters].
    Pons JC; Rais S; Diochin P; Frydman R
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(2):255-7. PubMed ID: 1583307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Extra-ovular instillation of glucose a contribution to the interruption of advanced pregnancy].
    Windisch WR
    Zentralbl Gynakol; 1974 May; 96(19):592-7. PubMed ID: 4409567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indications, techniques and complications of third trimester termination].
    Dommergues M
    J Gynecol Obstet Biol Reprod (Paris); 2002 Feb; 31(1 Suppl):2S78-83. PubMed ID: 11973525
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of prostaglandin E1 ovules in the therapeutic interruption of pregnancy in the 2d and 3d trimesters. Apropos of 46 cases].
    Monnier JC; Caron-Grillet C; Vinatier D; Patey-Savatier P; Maunoury-Lefebvre C
    Rev Fr Gynecol Obstet; 1987 Mar; 82(3):195-8. PubMed ID: 3589358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective first-trimester termination in octuplet and quadruplet pregnancies: clinical and ethical issues.
    Evans MI; Fletcher JC; Zador IE; Newton BW; Quigg MH; Struyk CD
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):289-96. PubMed ID: 3347412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiprogesterone for medical abortion].
    Khomasuridze AG; Tsertsvadze GL; Parculi MG; Parunashvili NR; Sulamanidze ShD
    Georgian Med News; 2006 Jun; (135):24-8. PubMed ID: 16905802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The "so called" therapeutic abortion without valid legislative supports in France].
    Soutoul JH; Body G; Gromb S; Pierre F
    Rev Fr Gynecol Obstet; 1991 Nov; 86(11):701-8. PubMed ID: 1780623
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pregnancy interruption and its complications].
    Schmidt-Matthiesen H
    Lebensversicher Med; 1980 May; 32(3):70-4. PubMed ID: 6110138
    [No Abstract]   [Full Text] [Related]  

  • 17. Fetal abnormalities leading to third trimester abortion: nine-year experience from a single medical center.
    Barel O; Vaknin Z; Smorgick N; Reish O; Mendlovic S; Herman A; Maymon R
    Prenat Diagn; 2009 Mar; 29(3):223-8. PubMed ID: 19177335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Technics for interruption of a second-trimester pregnancy].
    Ravina JH; Madelenat P
    Nouv Presse Med; 1974 Dec; 3(45):2733-6. PubMed ID: 4459866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The decision-making process and the outcome of therapeutic abortion.
    Friedman CM; Greenspan R; Mittleman F
    Am J Psychiatry; 1974 Dec; 131(12):1332-7. PubMed ID: 4432932
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ethical problems with the current French practice in therapeutic abortions. Part 3: resolving moral dilemmas in fetal medicine].
    Gold F; Hervé C; Taurelle R; Bauberot J; Pierre F; Descamps P; Laugier J
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(7):727-32. PubMed ID: 8568181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.